Cargando…
Drug idiosyncrasy due to pirfenidone presenting as acute liver failure: Case report and mini‐review of the literature
Idiosyncratic drug‐induced liver injury (DILI) is ranked among the top most common etiologies of acute liver failure (ALF). It carries poor transplant‐free survival. Pirfenidone is an anti‐inflammatory and antifibrotic drug that is commonly used for the treatment of idiopathic pulmonary fibrosis (IP...
Autores principales: | Verma, Nipun, Kumar, Pramod, Mitra, Suvradeep, Taneja, Sunil, Dhooria, Sahajal, Das, Ashim, Duseja, Ajay, Dhiman, Radha Krishan, Chawla, Yogesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796329/ https://www.ncbi.nlm.nih.gov/pubmed/29404521 http://dx.doi.org/10.1002/hep4.1133 |
Ejemplares similares
-
Neutrophil dysfunction predicts 90‐day survival in patients with acute on chronic liver failure: A longitudinal case–control study
por: Makkar, Kunaal, et al.
Publicado: (2020) -
Genetic polymorphism in CD14 gene, a co-receptor of TLR4 associated with non-alcoholic fatty liver disease
por: Kapil, Shweta, et al.
Publicado: (2016) -
Monocyte human leukocyte antigen – Antigen D related, neutrophil oxidative burst and cytokine analysis in patients of decompensated cirrhosis with and without acute-on chronic liver failure
por: Satsangi, Sandeep, et al.
Publicado: (2018) -
Is pirfenidone ready for use in non-idiopathic pulmonary fibrosis interstitial lung diseases?
por: Dhooria, Sahajal, et al.
Publicado: (2015) -
Vitamin D supplementation in patients with nonalcoholic fatty liver disease: A randomized controlled trial
por: Sakpal, Mallikarjun, et al.
Publicado: (2017)